A Systematic Review of Community Pharmacy‐Led Depression Services: Service Components, Outcomes, and Implementation Barriers and Facilitators
Open Access
- 1 January 2026
- journal article
- review article
- Published by Wiley in Depression and Anxiety
- Vol. 2026 (1) , 9977874
Abstract
Background: Depression is the most common mental ill health condition, and its prevalence is increasing. Despite this, its treatment is variable often due to a lack of capacity within healthcare systems to support this vulnerable population. Community pharmacy staff could offer additional support. This systematic review identifies depression services led by community pharmacy staff, their service components, outcomes, and barriers/facilitators to their implementation. Methods: Four bibliographic databases were searched (Medline, EMBASE, PsycINFO, and CINAHL) from 2000 onwards. Title/abstract and full‐text screening was conducted. Data on the service components were mapped to the Template for Intervention Description and Replication (TIDieR). Clinical, humanistic, economic, and service outcomes were charted. Barriers and facilitators were mapped to the Consolidated Framework for Implementation Research (CFIR). Quality assessment was performed using the Quality Assessment with Diverse Studies (QuADS) tool. Results: Fifty studies were included. Seventeen studies identified general attitudes regarding community pharmacy services for depression, which were generally supportive. The majority ( n = 33) explored an implemented depression service focusing on depression advice/education ( n = 15), screening ( n = 12), medication adherence ( n = 4), medication review ( n = 1), and disease therapy management (DTM) ( n = 1). Clinical outcomes were the most commonly reported types of outcomes, with varied results. Key facilitators were linked to the pharmacy ‘inner setting’, including accessibility of community pharmacies, the use of private consultation rooms, and skills/training of staff. Barriers to service delivery related often to the external ‘outer setting’, especially societal stigma, low public awareness of pharmacy roles, funding constraints, and limited collaboration with other healthcare professionals. Conclusion: This international review identified a range of different services that community pharmacy staff can deliver to support people with depression, ranging from supporting diagnosis, health literacy, and management plans. The accessibility of community pharmacies for depression service delivery warrants further investigation. However, limited empirical evidence of clinical and economic outcomes and reported implementation barriers may complicate broader implementation.Keywords
Funding Information
- Pharmacy Research UK (RGS\R2\222202)
This publication has 91 references indexed in Scilit:
- Patient outcomes following an intervention involving community pharmacists in the management of depressionAustralian Journal of Rural Health, 2006
- Depression Screening in a University Campus Pharmacy: A Pilot ProjectJournal of the American Pharmacists Association, 2006
- Improving Patient Feedback About and Outcomes with Antidepressant Treatment: A Study in Eight Community PharmaciesJournal of the American Pharmacists Association, 2006
- Use of community pharmacies: a population-based surveyJournal of Public Health, 2005
- Pharmacist Telemonitoring of Antidepressant Use: Effects on Pharmacist–Patient CollaborationJournal of the American Pharmacists Association, 2005
- A Pharmacy-Based Coaching Program to Improve Adherence to Antidepressant Treatment Among Primary Care PatientsPsychiatric Services, 2005
- Synthesising qualitative and quantitative evidence: A review of possible methodsJournal of Health Services Research & Policy, 2005
- Effects of coaching by community pharmacists on psychological symptoms of antidepressant users; a randomised controlled trialEuropean Neuropsychopharmacology, 2003
- Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trialEuropean Neuropsychopharmacology, 2003
- Effects of Pharmacist Monitoring on Patient Satisfaction With Antidepressant Medication TherapyJournal of the American Pharmaceutical Association, 2002